SEC Form 4/A · accession 0001179110-15-005615
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Brent L Saunders
Officer — CEO and President · Director
Period of report
Jul 1, 2014
Accepted (ET)
Mar 31, 2015 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2,F3 | Jul 1, 2014 | A | 135,507 | — | A | 135,507 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed solely to include 38,641 ordinary shares inadvertently omitted from the Reporting Person's Form 4 filed on July 3, 2014 following the Issuer's acquisition of Forest Laboratories, LLC (f/k/a Forest Laboratories,Inc.).
- F2On July 1, 2014, the Issuer ("Actavis") acquired Forest Laboratories, Inc. ("Forest") through a series of merger transactions which resulted in Forest becoming an indirect wholly-owned subsidiary of Actavis (the "Acquisition"). In connection with the Acquisition, each share of Forest common stock held by the Reporting Person was exchanged for $25.67 in cash plus 0.3326 of an Actavis ordinary share, with fractions of an Actavis ordinary share being cashed out at $219.00 per share.
- F3Includes 96,358 Actavis plc RSUs.